Cargando…

A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris

Human lysozyme (hLYZ), known for its bacteriolytic activity, is widely applied in the food and pharmaceutical industries as an antimicrobial agent. However, its extensive application was limited by its low large-scale production efficiency. In this study, a combinational method of integrating codon...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Huahua, Wu, Shijie, Mei, Meng, Ning, Jiali, Li, Chaoyin, Ma, Lixin, Zhang, Guimin, Yi, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075855/
https://www.ncbi.nlm.nih.gov/pubmed/32211388
http://dx.doi.org/10.3389/fbioe.2020.00118
_version_ 1783507101638721536
author He, Huahua
Wu, Shijie
Mei, Meng
Ning, Jiali
Li, Chaoyin
Ma, Lixin
Zhang, Guimin
Yi, Li
author_facet He, Huahua
Wu, Shijie
Mei, Meng
Ning, Jiali
Li, Chaoyin
Ma, Lixin
Zhang, Guimin
Yi, Li
author_sort He, Huahua
collection PubMed
description Human lysozyme (hLYZ), known for its bacteriolytic activity, is widely applied in the food and pharmaceutical industries as an antimicrobial agent. However, its extensive application was limited by its low large-scale production efficiency. In this study, a combinational method of integrating codon optimization, multiple gene copies, and ER molecular chaperone co-expression was developed to improve the heterologous production of hLYZ in Pichia pastoris GS115. Our results showed that increasing the copy number of the optimized hLYZ gene in P. pastoris could enhance its secretory production level up to 1.57-fold. The recombinant opt-hLYZ-6C strain that contains six copies of opt-hLYZ gene exhibited the highest mRNA transcription levels, giving the highest production of 0.22 ± 0.02 mg/mL of hLYZ in the medium supernatant with a bacteriolytic activity of 14,680 ± 300 U/mL against Micrococcus lysodeikticus in the shaking flask experiment. Moreover, co-overexpression of ER retention molecular chaperones, such as Pdi1 or Ero1, in the recombinant opt-hLYZ-6C strain both presented positive effects on the secretory production of hLYZ. Our further characterization indicated that tandem co-expression of Ero1 and Pdi1 together presented an added-up effect. The secretory production of hLYZ in the medium supernatant reached 0.34 ± 0.02 mg/mL of the recombinant opt-hLYZ-6C-EP strain in the shaking flask experiment, with a bacteriolytic activity of 21,200 ± 400 U/mL. Compared to the recombinant opt-hLYZ-1C strain, these final improvements were calculated as 2.43-fold and 2.30-fold on secretory protein levels and antibacterial activity, respectively. Finally, the recombinant opt-hLYZ-6C-EP strain was applied for high-density cultivation in 5 L of fermenter, in which the secretory yield of hLYZ reached 2.34 ± 0.02 mg/mL in the medium supernatant, with a bacteriolytic activity of 1.76 ± 0.02 × 10(5) U/mL against M. lysodeikticus. All these numbers presented the highest heterologous production levels of hLYZ in microbial systems.
format Online
Article
Text
id pubmed-7075855
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70758552020-03-24 A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris He, Huahua Wu, Shijie Mei, Meng Ning, Jiali Li, Chaoyin Ma, Lixin Zhang, Guimin Yi, Li Front Bioeng Biotechnol Bioengineering and Biotechnology Human lysozyme (hLYZ), known for its bacteriolytic activity, is widely applied in the food and pharmaceutical industries as an antimicrobial agent. However, its extensive application was limited by its low large-scale production efficiency. In this study, a combinational method of integrating codon optimization, multiple gene copies, and ER molecular chaperone co-expression was developed to improve the heterologous production of hLYZ in Pichia pastoris GS115. Our results showed that increasing the copy number of the optimized hLYZ gene in P. pastoris could enhance its secretory production level up to 1.57-fold. The recombinant opt-hLYZ-6C strain that contains six copies of opt-hLYZ gene exhibited the highest mRNA transcription levels, giving the highest production of 0.22 ± 0.02 mg/mL of hLYZ in the medium supernatant with a bacteriolytic activity of 14,680 ± 300 U/mL against Micrococcus lysodeikticus in the shaking flask experiment. Moreover, co-overexpression of ER retention molecular chaperones, such as Pdi1 or Ero1, in the recombinant opt-hLYZ-6C strain both presented positive effects on the secretory production of hLYZ. Our further characterization indicated that tandem co-expression of Ero1 and Pdi1 together presented an added-up effect. The secretory production of hLYZ in the medium supernatant reached 0.34 ± 0.02 mg/mL of the recombinant opt-hLYZ-6C-EP strain in the shaking flask experiment, with a bacteriolytic activity of 21,200 ± 400 U/mL. Compared to the recombinant opt-hLYZ-1C strain, these final improvements were calculated as 2.43-fold and 2.30-fold on secretory protein levels and antibacterial activity, respectively. Finally, the recombinant opt-hLYZ-6C-EP strain was applied for high-density cultivation in 5 L of fermenter, in which the secretory yield of hLYZ reached 2.34 ± 0.02 mg/mL in the medium supernatant, with a bacteriolytic activity of 1.76 ± 0.02 × 10(5) U/mL against M. lysodeikticus. All these numbers presented the highest heterologous production levels of hLYZ in microbial systems. Frontiers Media S.A. 2020-03-10 /pmc/articles/PMC7075855/ /pubmed/32211388 http://dx.doi.org/10.3389/fbioe.2020.00118 Text en Copyright © 2020 He, Wu, Mei, Ning, Li, Ma, Zhang and Yi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
He, Huahua
Wu, Shijie
Mei, Meng
Ning, Jiali
Li, Chaoyin
Ma, Lixin
Zhang, Guimin
Yi, Li
A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title_full A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title_fullStr A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title_full_unstemmed A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title_short A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris
title_sort combinational strategy for effective heterologous production of functional human lysozyme in pichia pastoris
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075855/
https://www.ncbi.nlm.nih.gov/pubmed/32211388
http://dx.doi.org/10.3389/fbioe.2020.00118
work_keys_str_mv AT hehuahua acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT wushijie acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT meimeng acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT ningjiali acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT lichaoyin acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT malixin acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT zhangguimin acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT yili acombinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT hehuahua combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT wushijie combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT meimeng combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT ningjiali combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT lichaoyin combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT malixin combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT zhangguimin combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris
AT yili combinationalstrategyforeffectiveheterologousproductionoffunctionalhumanlysozymeinpichiapastoris